Disorders of the posterior pituitary Flashcards
Disorders of posterior pituitary
Diabetes insipidus, SIADH (syndrome of inappropriate secretion of ADH)
Diabetes insipidus, central type (ADH deficiency)
Major causes are: trauma, tumors of the hypothalamus, rare inflammatory diseases (histiocytosis X, sarcoidosis), intracranial bleeding, Sheehan syndrome, congenital forms.
Tests for central type of diabetes insipidus: Oral water and salt test (20ml/kg water and 0.9% NaCl) on two consecutive days. In normal individuals the diuresis after salt intake is less than before salt intake.
Treatment of central type of diabetes insipidus: ADH-analogue called desmopressin. Can be administered intranasally (nasal spray) or through tablets (3x 100-200 micrograms/day).
Diabetes insipidus, nephrogenic type
A disorder of renal ADH action, rather than a deficiency of ADH. Two major forms of the disease: rare congenital form, acquired form (chronic renal disease, metabolic disturbances). Treatment through NSAIDS - which decreases the polyuria and increases osmolarity, Tiazide - mild diuretics.
It is transitional in pregnancy due to an increased metabolism of ADH.
Primary polydipsia
Psychological disorder
Symptoms of diabetes insipidus
Polyuria (up to 18-20 liters/day in severe cases.
Polydipsia.
Low urinary density and urinary osmolarity.
DI patients cannot concentrate urine even in the case of fluid intake restriction.
General information of SIADH
It is usually considered a major characteristic of paraneoplastic syndrome. Can be secondary to small cell lung cancer, carcinoids, or prostate cancer.
Consequences of SIADH
Severe hyponatremia (often less than 120mmol/L) Serum hypoosmolarity (often less than 275mOsm/kg) Coma and seizures in severe forms
Diagnostic signs of SIADH
Hypoosmolar serum, and highly concentrated urine
Hyponatremia, high urinary Na concentration
Lack of edema
Differential diagnosis (causes other than paraneoplastic)
Hypothyroidsm, Addisons-disease, hypopituitarism, drugs, CNS diseases
Treatment of SIADH
In severe cases (when serum Na is less than 120 mmol/L) Hypertonic salt infusion, goal is 125 mmol/L Na conc. Speed of normalization cannot be larger than 0,5 mmol/h, due to danger of central pontine myelinolysis.
In milder cases (when serum Na is more than 120mmol/L) fluid restriction is used. Daily intake as low as 800-1000ml. Demeclocyclin can also be used as it inhibits renal ADH action in chronic cases.